Table 3.
Outcomes and complications of organ recipients from standard versus marginal donors.
| SDs (n = 174) | MDs (n = 64) | p | |
|---|---|---|---|
| n (%) or Median (IQR) | n (%) or Median (IQR) | ||
| Severe PGF | 36 (20.7%) | 18 (28.1%) | 0.2 |
| Postoperative ECMO support (days) | 5.0 (3.0–6.5) | 3.5 (2.0–6.8) | 0.2 |
| CVVH | 54 (31.0%) | 32 (50.0%) | 0.01 |
| Intrahospital infection | 61 (35.1%) | 30 (46.9%) | 0.1 |
| Clinical cellular rejection | 62 (35.6%) | 24 (37.5%) | 0.9 |
| CAV | 28 (16.1%) | 14 (21.9%) | 0.6 |
| Cerebral event | 17 (9.8%) | 12 (18.8%) | 0.07 |
| 30-day mortality | 13 (7.5%) | 9 (14.1%) | 0.1 |
| Hospital mortality | 21 (12.1%) | 15 (23.4%) | 0.04 |
| Cause of hospital mortality | |||
| MOF | 10 (47.6%) | 11 (73.3%) | |
| Neurologic | 2 (9.5%) | 1 (6.7%) | |
| Infection | 4 (19.1%) | 3 (20.0%) | |
| Other | 5 (23.8%) | 0 (0.0%) |
Abbreviations: CAV, cardiac graft vasculopathy; CVVH, continuous venovenous hemofiltration; ECMO, extracorporeal membrane oxygenator; MOF: multiorgan failure; PGF, primary graft failure.